Lotte Steuten | Associate Faculty Member
Fred Hutchinson Cancer Research Center

Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center

Dr. Lotte Steuten is an entrepreneurial academic, striving to accelerate patient access to high-value healthcare innovations. She has deep expertise in health economics and evidence development that she applies to identifying and articulating the clinical, humanistic and economic value of medical technologies and precision medicine. As an Associate Member at Fred Hutch and Affiliate Associate Professor at the University of Washington, Seattle (WA), Lotte conducts an active research program in comparative effectiveness research and health policy. She is an advisor to various research organizations, policy boards and healthcare industries and is co-founder and Chief Scientific Officer of Panaxea - a medtech consulting firm. Lotte accrued her global expertise at leading health economic groups in the US, UK and the Netherlands. She obtained an MSc in Health Sciences and a PhD (cum laude) in Health Economics from Maastricht University, the Netherlands.


Pharma Pricing & Market Access USA Day 1 @ 16:10

PANEL: The impact of precision medicine and biomarkers on drug pricing structures

  • Understanding how biomarkers will have an increasing role to play in drug pricing 
  • What impact will precision medicine have on the overall cost of healthcare
  • Do we have the necessary evidence to put a price on precision medicine?

back to speakers